Literature DB >> 29631332

Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis.

Dirk J van der Windt1, Vikas Sud1, Hongji Zhang1,2, Patrick R Varley1, Julie Goswami1, Hamza O Yazdani1, Samer Tohme1, Patricia Loughran3, Robert M O'Doherty4, Marta I Minervini5, Hai Huang1,2, Richard L Simmons1, Allan Tsung1.   

Abstract

Nonalcoholic steatohepatitis (NASH) is a progressive, inflammatory form of fatty liver disease. It is the most rapidly rising risk factor for the development of hepatocellular carcinoma (HCC), which can arise in NASH with or without cirrhosis. The inflammatory signals promoting the progression of NASH to HCC remain largely unknown. The propensity of neutrophils to expel decondensed chromatin embedded with inflammatory proteins, known as neutrophil extracellular traps (NETs), has been shown to be important in chronic inflammatory conditions and in cancer progression. In this study, we asked whether NET formation occurs in NASH and contributes to the progression of HCC. We found elevated levels of a NET marker in serum of patients with NASH. In livers from STAM mice (NASH induced by neonatal streptozotocin and high-fat diet), early neutrophil infiltration and NET formation were seen, followed by an influx of monocyte-derived macrophages, production of inflammatory cytokines, and progression of HCC. Inhibiting NET formation, through treatment with deoxyribonuclease (DNase) or using mice knocked out for peptidyl arginine deaminase type IV (PAD4-/- ), did not affect the development of a fatty liver but altered the consequent pattern of liver inflammation, which ultimately resulted in decreased tumor growth. Mechanistically, we found that commonly elevated free fatty acids stimulate NET formation in vitro.
CONCLUSION: Our findings implicate NETs in the protumorigenic inflammatory environment in NASH, suggesting that their elimination may reduce the progression of liver cancer in NASH. (Hepatology 2018).
© 2018 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29631332      PMCID: PMC6173613          DOI: 10.1002/hep.29914

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  40 in total

Review 1.  NAFLD and liver transplantation: Current burden and expected challenges.

Authors:  Raluca Pais; A Sidney Barritt; Yvon Calmus; Olivier Scatton; Thomas Runge; Pascal Lebray; Thierry Poynard; Vlad Ratziu; Filomena Conti
Journal:  J Hepatol       Date:  2016-07-30       Impact factor: 25.083

2.  Damage-associated molecular pattern-activated neutrophil extracellular trap exacerbates sterile inflammatory liver injury.

Authors:  Hai Huang; Samer Tohme; Ahmed B Al-Khafaji; Sheng Tai; Patricia Loughran; Li Chen; Shu Wang; Jiyun Kim; Timothy Billiar; Yanming Wang; Allan Tsung
Journal:  Hepatology       Date:  2015-05-29       Impact factor: 17.425

Review 3.  Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.

Authors:  Jessica Zucman-Rossi; Augusto Villanueva; Jean-Charles Nault; Josep M Llovet
Journal:  Gastroenterology       Date:  2015-06-20       Impact factor: 22.682

4.  Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans is Associated With Nonalcoholic Fatty Liver Disease.

Authors:  Sahil Mittal; Hashem B El-Serag; Yvonne H Sada; Fasiha Kanwal; Zhigang Duan; Sarah Temple; Sarah B May; Jennifer R Kramer; Peter A Richardson; Jessica A Davila
Journal:  Clin Gastroenterol Hepatol       Date:  2015-07-18       Impact factor: 11.382

Review 5.  Neutrophil extracellular traps: protagonists of cancer progression?

Authors:  L Erpenbeck; M P Schön
Journal:  Oncogene       Date:  2016-12-12       Impact factor: 9.867

6.  Hepatic free fatty acids accumulate in experimental steatohepatitis: role of adaptive pathways.

Authors:  Claire Z Larter; Matthew M Yeh; W Geoffrey Haigh; Jacqueline Williams; Sandie Brown; Kim S Bell-Anderson; Sum P Lee; Geoffrey C Farrell
Journal:  J Hepatol       Date:  2008-01-28       Impact factor: 25.083

Review 7.  Inflammation in Alcoholic and Nonalcoholic Fatty Liver Disease: Friend or Foe?

Authors:  Bin Gao; Hidekazu Tsukamoto
Journal:  Gastroenterology       Date:  2016-01-27       Impact factor: 22.682

8.  A proposed role for neutrophil extracellular traps in cancer immunoediting.

Authors:  Sivan Berger-Achituv; Volker Brinkmann; Ulrike Abu Abed; Lars I Kühn; Jonathan Ben-Ezra; Ronit Elhasid; Arturo Zychlinsky
Journal:  Front Immunol       Date:  2013-03-06       Impact factor: 7.561

9.  Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat Load.

Authors:  Roberto Gambino; Elisabetta Bugianesi; Chiara Rosso; Lavinia Mezzabotta; Silvia Pinach; Natalina Alemanno; Francesca Saba; Maurizio Cassader
Journal:  Int J Mol Sci       Date:  2016-03-31       Impact factor: 5.923

10.  NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.

Authors:  Chi Ma; Aparna H Kesarwala; Tobias Eggert; José Medina-Echeverz; David E Kleiner; Ping Jin; David F Stroncek; Masaki Terabe; Veena Kapoor; Mei ElGindi; Miaojun Han; Angela M Thornton; Haibo Zhang; Michèle Egger; Ji Luo; Dean W Felsher; Daniel W McVicar; Achim Weber; Mathias Heikenwalder; Tim F Greten
Journal:  Nature       Date:  2016-03-02       Impact factor: 49.962

View more
  102 in total

1.  MicroRNA-223 Ameliorates Nonalcoholic Steatohepatitis and Cancer by Targeting Multiple Inflammatory and Oncogenic Genes in Hepatocytes.

Authors:  Yong He; Seonghwan Hwang; Yan Cai; Seung-Jin Kim; Mingjiang Xu; Dingcheng Yang; Adrien Guillot; Dechun Feng; Wonhyo Seo; Xin Hou; Bin Gao
Journal:  Hepatology       Date:  2019-06-05       Impact factor: 17.425

Review 2.  Neutrophil Recruitment: From Model Systems to Tissue-Specific Patterns.

Authors:  Andreas Margraf; Klaus Ley; Alexander Zarbock
Journal:  Trends Immunol       Date:  2019-06-04       Impact factor: 16.687

Review 3.  Neutrophils in the Tumor Microenvironment.

Authors:  Lingyun Wu; Sugandha Saxena; Rakesh K Singh
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 4.  Extracellular Trap by Blood Cells: Clinical Implications.

Authors:  R J Nija; S Sanju; Neeraj Sidharthan; Ullas Mony
Journal:  Tissue Eng Regen Med       Date:  2020-02-29       Impact factor: 4.169

Review 5.  Neutrophil Extracellular Traps and Liver Disease.

Authors:  Moira B Hilscher; Vijay H Shah
Journal:  Semin Liver Dis       Date:  2019-11-14       Impact factor: 6.115

Review 6.  The Role of Innate Immune Cells in Nonalcoholic Fatty Liver Disease.

Authors:  Marina Nati; Kyoung-Jin Chung; Triantafyllos Chavakis
Journal:  J Innate Immun       Date:  2021-08-24       Impact factor: 7.349

Review 7.  The complexity of neutrophils in health and disease: Focus on cancer.

Authors:  Silvia Carnevale; Somayehsadat Ghasemi; Anna Rigatelli; Sebastien Jaillon
Journal:  Semin Immunol       Date:  2020-09-18       Impact factor: 11.130

Review 8.  Neutrophil diversity and plasticity in tumour progression and therapy.

Authors:  Sebastien Jaillon; Andrea Ponzetta; Diletta Di Mitri; Angela Santoni; Raffaella Bonecchi; Alberto Mantovani
Journal:  Nat Rev Cancer       Date:  2020-07-21       Impact factor: 60.716

9.  Serum levels of inflammatory markers CRP, ESR and albumin in relation to survival for patients with hepatocellular carcinoma.

Authors:  Hikmet Akkiz; Brian I Carr; Harika G Bag; Ümit Karaoğullarından; Kendal Yalçın; Nazim Ekin; Ayşegül Özakyol; Engin Altıntaş; Hatice Y Balaban; Halis Şimşek; Ahmet Uyanıkoğlu; Ayhan Balkan; Sedef Kuran; Oğuz Üsküdar; Yakup Ülger; Burak Güney; Anil Delik
Journal:  Int J Clin Pract       Date:  2020-12-12       Impact factor: 2.503

10.  Neutrophil extracellular traps as a novel biomarker to predict recurrence-free and overall survival in patients with primary hepatic malignancies.

Authors:  Christof T Kaltenmeier; Hamza Yazdani; Dirk van der Windt; Michele Molinari; David Geller; Allan Tsung; Samer Tohme
Journal:  HPB (Oxford)       Date:  2020-08-15       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.